Industry: Blood diagnostics

More than 1.4 million heart attacks or strokes happen to people in the U.S. each year. While anti-platelet drugs are effective and available, patients do not respond uniformly to them. Moreover, doctors lack information when determining which drug, at what dosage, is appropriate.

ThrombusCheck is a device that simulates reactions to heart medications. The technology provides doctors with quantified projections for platelet function on a proposed drug regimen, guiding prescriptions for more effective treatment and better patient outcomes.

Back to companies